| dc.description.abstract |
Urinary tract infections are among the most prevalent extra-intestinal infec
tions, with high prevalence globally. This cross-sectional study established
prevalence of bacterial aetiology causing urinary tract infection (UTI) and
their antimicrobial susceptibility profiles. A questionnaire was used to cap
ture socio-demographic data and possible UTI risk factors among the 206
consented adults seeking medicare at Kiambu Level 5 Hospital. The collected
midstream urine samples were subjected to dipstick analysis, microscopy and
culture for UTI diagnosis. Results: The overall prevalence rate of UTIs was
27.6%, with women’s prevalence rate being significantly higher at 80.7%
compared to men 19.2%. Pregnant women had UTI prevalence at 34% which
was higher than other sets of participants. Women who did not frequently
change their underpants daily had a higher UTI cases at 34.8%. Escherichia
coli, Staphylococcus aureus and Klebsiella pneumoniae were the most preva
lent bacterial pathogens at 38.5%, 21% and 19.3%, respectively. Antimicrobial
sensitivity analysis revealed high resistances towards Sulfamethoxazole and
Ampicillin at range between 50% - 85%, suggesting that these drugs are no
longer effective for UTI empirical treatment. The resistance patterns towards
Cefotaxime, Cefepime and Ciprofloxacin were below 40%. However, more
resistance patterns at a range between 14% - 40% revealed towards Amoxicil
lin-clavulanic and Nitrofurantoin imply that these are drugs remain potent
but there is the need to revise the current UTI management guidelines. In ad
DOI: 10.4236/aim.2021.118028 Aug. 2, 2021
360
Advances in Microbiology
F. Wanja et al.
dition, to elude treatment failure, innovation of prophylactic measures is key
to halt UTI contraction and offer support to pharmaceutical industries that
have fewer new antibiotics in the pipeline.
Keywords
Urinary Tract Infection (UTI), Risk Factors, Antimicrobial Resistance and
Antimicrobial Susceptibility Profile |
en_US |